Article content

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Cosm Medical Corp. (https://www.cosm.care), a leader in personalized gynecological medical devices, has entered into a licensing and collaboration agreement with two leading academic medical centers to develop Gynethotics™ Recovery—personalized intravaginal devices for post-surgical pelvic recovery following reconstructive surgery.
Article content
Article content
TORONTO — Cosm Medical Corp., a medical technology company specializing in personalized gynecological devices, today announced that it has entered into a licensing and collaboration agreement with Duke Health and Mayo Clinic to develop and commercialize a new class of personalized devices designed for post-surgical recovery.
Article content
Article content
Under the agreement, Cosm Medical has licensed intellectual property from both institutions related to a novel device design and clinical use following pelvic reconstructive surgery. The collaboration will focus on product evaluation, clinical validation, and the potential commercialization of personalized recovery devices intended to support healing, improve anatomical outcomes, and enhance patient comfort and quality of life.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Advancing Precision in Post-Surgical Pelvic Care
Article content
Gynethotics™ Recovery builds on Cosm Medical’s patented digital gynecology platform, which integrates medical imaging and 3D-printing to deliver personalized biocompatible devices. The new Gynethotics™ Recovery line is designed to add new ways to advance the widespread use of non-invasive devices in pelvic care.
Article content
This initiative seeks to reflect a broader shift in healthcare toward precision medicine and, within pelvic health, where personalized devices can address anatomical variability and improve outcomes compared to traditional one-size-fits-all pessaries and beyond.
Article content
“We see personalization for precision as the next frontier in pelvic health,” said Derek Sham, Founder and CEO of Cosm Medical. “Precision unlocks new clinical applications for medical devices in gynecology. The goal of this collaboration is to advance a standard of care aligned with fields like orthopaedics and dentistry, where custom-fabricated devices are already well established. By combining clinical expertise with a scalable precision care platform, we believe Gynethotics™ Recovery has the potential to redefine post-surgical healing and improve outcomes for patients worldwide.”
Article content
“Tissue remodeling and personalized support can play a key role in improving surgical outcomes and patient experience,” said Dr Cassandra Kisby, Assistant Professor of Obstetrics and Gynecology at Duke University’s School of Medicine. “Moving beyond one-size-fits-all, historically rooted practices toward an evidence-driven, personalized paradigm marks a pivotal shift in surgical recovery.”
Article content
About Cosm Medical
Article content
Cosm Medical Corp. (
Article content
Article content
) is a Toronto-based medical technology company pioneering precision pelvic care through its digital gynecology platform, enabling the fabrication of personalized gynecological devices (Gynethotics™) for conditions such as pelvic organ prolapse, incontinence, and post-surgical recovery. Cosm’s mission is to bring personalized care to women’s pelvic health.
Article content
Article content
For more information, visit: www.cosm.careMayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.Duke Health has a financial interest in the technology referenced in this press release. Duke Health will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content

Article content
Contacts
Article content
Media Contact:
Derek Sham, Founder and CEO
Cosm Medical Corp.
[email protected] | +1 (647) 965-5300
Article content

1 hour ago
3
English (US)